Search Results - "Vazquez, Isabel Palacio"

Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial by Fujiwara, Keiichi, Fujiwara, Hiroyuki, Yoshida, Hiroyuki, Satoh, Toyomi, Yonemori, Kan, Nagao, Shoji, Matsumoto, Takashi, Kobayashi, Hiroaki, Bourgeois, Hughes, Harter, Philipp, Mosconi, Anna Maria, Vazquez, Isabel Palacio, Reinthaller, Alexander, Fujita, Tomoko, Rowe, Philip, Pujade-Lauraine, Eric, Ray-Coquard, Isabelle

“…The addition of maintenance olaparib to bevacizumab demonstrated a significant progression-free survival (PFS) benefit in patients with newly diagnosed,…”
Get full text

Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial by Oza, Amit M, Matulonis, Ursula A, Malander, Susanne, Hudgens, Stacie, Sehouli, Jalid, del Campo, Josep M, Berton-Rigaud, Dominique, Banerjee, Susana, Scambia, Giovanni, Berek, Jonathan S, Lund, Bente, Tinker, Anna V, Hilpert, Felix, Vázquez, Isabel Palacio, D'Hondt, Véronique, Benigno, Benedict, Provencher, Diane, Buscema, Joseph, Agarwal, Shefali, Mirza, Mansoor R

“…Quality of life (QOL) has become an important complementary endpoint in cancer clinical studies alongside more traditional assessments (eg, tumour response,…”
Get full text

Mechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome It by María Luque-Cabal, Paula García-Teijido, Yolanda Fernández-Pérez, Luisa Sánchez-Lorenzo, Isabel Palacio-Vázquez

“…The introduction of trastuzumab therapy markedly improved the poor prognosis associated with HER2-amplified breast cancers. Despite this, the presence of…”
Get full text

Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial by Fabbro, Michel, Moore, Kathleen N., Dørum, Anne, Tinker, Anna V., Mahner, Sven, Bover, Isabel, Banerjee, Susana, Tognon, Germana, Goffin, Frederic, Shapira-Frommer, Ronnie, Wenham, Robert M., Hellman, Kristina, Provencher, Diane, Harter, Philipp, Vázquez, Isabel Palacio, Follana, Philippe, Pineda, Mario J., Mirza, Mansoor R., Hazard, Sebastien J., Matulonis, Ursula A.

“…To analyze the safety and efficacy of niraparib in patients aged ≥70 years with recurrent ovarian cancer in the ENGOT-OV16/NOVA trial. The trial enrolled 2…”
Get full text

Laboratory cross-comparison of homologous recombination repair mutation analysis in tumor in a multicenter epithelial ovarian cancer series: The BORNEO GEICO 60-0 study by Romero, Ignacio, Oaknin, Ana, Garcia-Casado, Zaida, Marquez, Raul, Yubero Esteban, Alfonso, Gallego, Alejandro, Sanchez, Ana Beatriz, Pérez Segura, Cristina, Alarcon Company, Jesus, Barretina Ginesta, Pilar, Palacio Vázquez, Isabel, Fariñas Madrid, Lorena, Cueva, Juan Fernando, Matito, Judit, Poveda, Andres, Lopez-Guerrero, Jose Antonio, Vivancos, Ana

“…Abstract only e17550 Background: In epithelial ovarian cancer (EOC), the identification of mutations in homologous recombination repair (HRR) genes on tumor is…”
Get full text

Laboratory cross-comparison of tumor BRCA1/2 analysis in a multicenter epithelial ovarian cancer series: The BORNEO GEICO60-0 study by Romero, Ignacio, Oaknin, Ana, Garcia-Casado, Zaida, Marquez, Raul, Yubero Esteban, Alfonso, Gallego, Alejandro, Sanchez, Ana Beatriz, Perez Segura, Cristina, Alarcon, Jesus, Barretina-Ginesta, Maria Pilar, Palacio Vázquez, Isabel, Farinas-Madrid, Lorena, Cueva, Juan Fernando, Matito, Judit, Poveda, Andres, Lopez Guerrero, Jose Antonio, Vivancos, Ana

“…Abstract only 6055 Background: Epithelial ovarian cancer (EOC) identification of BRCA1 and BRCA2 mutations is usually carried out in germline, representing…”
Get full text

Optimizing the febrile neutropenia care process in cancer patients in a third level Spanish hospital by Solis-Hernandez, Maria Pilar, Mihic Góngora, Luka, Contreras Toledo, Debora Corina, Iglesias Gomez, Clara, Fernandez Arrojo, Sara, Alvarez Fernandez, Carlos, Jiménez Fonseca, Paula, Izquierdo Manuel, Marta, Revuelta, Alfonso, Gómez, David, del Río Fernández, Jorge, Valcárcel González, Sena, Muniz Castrillo, Maria, Castillo Trujillo, Oscar Alfredo, Villanueva, Noemí, Garcia Llano, Juan Luis, Palacio Vázquez, Isabel, Fernandez Perez, Yolanda, Esteban, Emilio

“…Abstract only e14034 Background: Cancer patients under cytotoxic treatment with fever used to have an average time of antibiotics administration of 11h (median…”
Get full text

Mechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome It by María Luque-Cabal, Paula García-Teijido, Yolanda Fernández-Pérez, Luisa Sánchez-Lorenzo, Isabel Palacio-Vázquez

Get full text